SMAD4 and ovarian carcinoma: MiR-183 is highly expressed in ovarian cancer cells (Wang et al., 2014; Chen et al., 2016) and down-regulation of miR-183 markedly represses cell proliferation and promotes apoptosis via targeting SMAD family member 4 (Smad4) (Zhou et al., 2019).